20 May 2013
Keywords: ligand, alrt, retinoids, progress, joint-venture, company, allergan
Article | 15 January 1996
Joint-venture company Allergan Ligand Retinoid Therapeutics has started a Phase III clinical trial of ALRT1057 Topical (9-cis-retinoic acid) for the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.